Cancers, Vol. 16, Pages 1776: The Current Role of Radiation in the Management of Cholangiocarcinoma & mdash;A Narrative Review
Cancers, Vol. 16, Pages 1776: The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review
Cancers doi: 10.3390/cancers16091776
Authors:
Saurav Verma
Natalie Grindrod
Daniel Breadner
Michael Lock
Cholangiocarcinoma (CCA) is a rare cancer of bile ducts. It is associated with a poor prognosis. The incidence of CCA is rising worldwide. Anatomical subgroups have been used to classify patients for treatment and prognosis. There is a growing understanding of clinically important distinctions based on underlying genetic differences that lead to different treatment options and outcomes. Its management is further complicated by a heterogeneous population and relative rarity, which limits the conduct of large trials to guide management. Surgery has been the primary method of therapy for localized disease; however, recurrence and death remain high with or without surgery. Therefore, there have been concerted efforts to investigate new treatment options, such as the use of neoadjuvant treatments to optimize surgical outcomes, targeted therapy, leveraging a new understanding of immunobiology and stereotactic radiation. In this narrative review, we address the evidence to improve suboptimal outcomes in unresectable CCA with radiation, as well as the role of radiation in neoadjuvant and postoperative treatment. We also briefly discuss the recent developments in systemic treatment with targeted therapies and immune checkpoint inhibitors.
Source: Cancers - Category: Cancer & Oncology Authors: Saurav Verma Natalie Grindrod Daniel Breadner Michael Lock Tags: Review Source Type: research
More News: Bile | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Genetics | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy